prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |review
The study aimed to evaluate the effectiveness of two management strategies for patients presenting in primary care with symptoms of dyspepsia. Two randomised controlled trials were conducted concurrently, with eligibility being determined by the patient's age at presentation. Randomisation was at the individual patient level .

Initial endoscopy trial:
Eligible patients: 50 years of age or older.
Intervention: Referred for open access endoscopy.

Test and endoscopy trial
Eligible patients: Under 50 years.
Intervention: Test for Helicobacter pylori antibodies with Helisal near patient test. Patients with positive results referred for open access endoscopy; those with negative results received symptomatic treatment only.
Control arms (both trials): Managed according to "usual practice" excluding open access endoscopy. This included antacids, H2 receptor antagonists, proton pump inhibitors, outpatient gastroenterology referral, facilitated or direct access endoscopy (for example, vetted by consultant), and testing for H pylori.
Outcomes:
Primary outcomes change in symptom score and cost effectiveness. Secondary outcomes quality of life and acceptability.